C07C 255/59
The carbon skeleton being further substituted by singly-bound oxygen atoms
Official title: the carbon skeleton being further substituted by singly-bound oxygen atoms
C07C255/59 (The carbon skeleton being further substituted by singly-bound oxygen atoms) appears on 132 US grants and 153 published applications in this corpus.
Search patents in C07C- Granted patents
- 132
- Published applications
- 153
- Assignees
- 124
- Inventors
- 599
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 4 | 0 |
| 1998 | 5 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 4 |
| 2003 | 2 | 5 |
| 2004 | 5 | 17 |
| 2005 | 3 | 4 |
| 2006 | 8 | 7 |
| 2007 | 3 | 5 |
| 2008 | 2 | 7 |
| 2009 | 7 | 8 |
| 2010 | 4 | 7 |
| 2011 | 6 | 8 |
| 2012 | 6 | 4 |
| 2013 | 3 | 3 |
| 2014 | 4 | 10 |
| 2015 | 6 | 7 |
| 2016 | 7 | 7 |
| 2017 | 5 | 5 |
| 2018 | 5 | 3 |
| 2019 | 6 | 6 |
| 2020 | 4 | 5 |
| 2021 | 1 | 7 |
| 2022 | 4 | 4 |
| 2023 | 5 | 8 |
| 2024 | 4 | 6 |
| 2025 | 4 | 5 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- HSD17B13 inhibitors and uses thereof2 Jun 2026US 12,643,858 B2Inipharm, Inc.
- Method for purifying key intermediates of citalopram9 Dec 2025US 12,492,165 B2Zhejiang Huahai LiCheng Pharmaceutical Co., Ltd.
- Aromatic compound and preparation method therefor and use thereof8 Jul 2025US 12,351,565 B2Shanghai Zhigen Pharmaceutical & Technology Co., Ltd.
- Aminotetraline activators of serotonin receptors1 Jul 2025US 12,344,570 B2Atai Therapeutics, Inc.
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Aminotetraline activators of serotonin receptors11 Sep 2025US 2025/0282708 A1Atai Therapeutics, Inc.
- Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha3 Jul 2025US 2025/0214930 A1Arcus Biosciences, Inc.
- Aminoketone compound, and preparation method therefor and use thereof5 Jun 2025US 2025/0177324 A1Shanghai Zhigen Pharmaceutical & Technology Co., Ltd.
- Processes and intermediates for preparing mcl1 inhibitors5 Jun 2025US 2025/0179004 A1Gilead Sciences, Inc.
Most cited
By later US patents
- 9-substituted minocycline compounds83US 6,846,939 B2Paratek Pharmaceuticals, Inc. · 2005
- Anthranilic acid derivatives78US 5,716,993 AEisai Co., Ltd. · 1998
- Inhibitors of histone deacetylase67US 6,897,220 B2MethylGene Inc. · 2005
- Cycloalkyl tachykinin receptor antagonists44US 5,750,549 AMerck & Co., Inc. · 1998
- 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands36US 7,132,445 B2Pharmacopeia Drug Discovery, Inc. · 2006